Any ideas? Both drugs have been around for 20+ years. They stopped making Alteron 5 years ago I can only assume because there is no market for it. They aren't taking steps to get Ampligen approved for anything much less CFS, nor do they have the money for the additional trial.
So how are they going to make money for the shareholders, support operations and pay the million dollar a year CEO?